XRCC1: A potential prognostic and immunological biomarker in low-grade gliomas

A new research paper titled “XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis” has been published in Aging.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup